196 related articles for article (PubMed ID: 27454862)
1. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy.
Korzon-Burakowska A; Jakóbkiewicz-Banecka J; Fiedosiuk A; Petrova N; Koblik T; Gabig-Cimińska M; Edmonds M; Małecki MT; Węgrzyn G
Diabet Med; 2012 Jun; 29(6):771-5. PubMed ID: 21913967
[TBL] [Abstract][Full Text] [Related]
3. [Early development of Charcot neuroarthropathy in the course of compensated diabetes mellitus--case report].
Kamińska A; Kamiński M; Jesionka P; Szymkowiak E; Bronisz A; Zmudzińska M; Junik R; Sikorska Z
Pol Arch Med Wewn; 2004 Jun; 111(6):709-13. PubMed ID: 15508794
[TBL] [Abstract][Full Text] [Related]
4. Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.
Nissim A; Winyard PG; Corrigall V; Fatah R; Perrett D; Panayi G; Chernajovsky Y
Arthritis Rheum; 2005 Dec; 52(12):3829-38. PubMed ID: 16329077
[TBL] [Abstract][Full Text] [Related]
5. Charcot neuroarthropathy: An often overlooked complication of diabetes.
Botek G; Anderson MA; Taylor R
Cleve Clin J Med; 2010 Sep; 77(9):593-9. PubMed ID: 20810870
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
[TBL] [Abstract][Full Text] [Related]
7. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
[TBL] [Abstract][Full Text] [Related]
8. Charcot neuroarthropathy in diabetes mellitus.
Rajbhandari SM; Jenkins RC; Davies C; Tesfaye S
Diabetologia; 2002 Aug; 45(8):1085-96. PubMed ID: 12189438
[TBL] [Abstract][Full Text] [Related]
9. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging.
Höpfner S; Krolak C; Kessler S; Tiling R; Brinkbäumer K; Hahn K; Dresel S
Foot Ankle Int; 2004 Dec; 25(12):890-5. PubMed ID: 15680102
[TBL] [Abstract][Full Text] [Related]
10. Trabecular quality and cellular characteristics of normal, diabetic, and charcot bone.
La Fontaine J; Shibuya N; Sampson HW; Valderrama P
J Foot Ankle Surg; 2011; 50(6):648-53. PubMed ID: 21705241
[TBL] [Abstract][Full Text] [Related]
11. Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy.
Valabhji J; Marshall RC; Lyons S; Bloomfield L; Hogg D; Rosenfeld P; Gabriel CM
Diabet Med; 2012 Sep; 29(9):1191-4. PubMed ID: 22276944
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of the acute Charcot foot in diabetes.
Rudrappa S; Game F; Jeffcoate W
Diabet Med; 2012 Jun; 29(6):819-21. PubMed ID: 22587408
[TBL] [Abstract][Full Text] [Related]
13. Diabetic neuroarthropathy of the shoulder.
Clayton M; Taylor BC; Backes J
Orthopedics; 2010 Aug; 33(8):. PubMed ID: 20704097
[TBL] [Abstract][Full Text] [Related]
14. The Charcot joint: a modern neurologic perspective.
Chisholm KA; Gilchrist JM
J Clin Neuromuscul Dis; 2011 Sep; 13(1):1-13. PubMed ID: 22361621
[TBL] [Abstract][Full Text] [Related]
15. HIV neuropathy induced Charcot neuroarthropathy: a case discussion.
Young N; Neiderer K; Martin B; Jolley D; Dancho JF
Foot (Edinb); 2012 Sep; 22(3):112-6. PubMed ID: 22391513
[TBL] [Abstract][Full Text] [Related]
16. Charcot foot osteoarthropathy in diabetes mellitus.
Wilson M
Mil Med; 1991 Oct; 156(10):563-9. PubMed ID: 1749505
[TBL] [Abstract][Full Text] [Related]
17. Loss of RAGE defense: a cause of Charcot neuroarthropathy?
Witzke KA; Vinik AI; Grant LM; Grant WP; Parson HK; Pittenger GL; Burcus N
Diabetes Care; 2011 Jul; 34(7):1617-21. PubMed ID: 21593297
[TBL] [Abstract][Full Text] [Related]
18. The neuropathic foot in diabetes. Part II: Charcot's neuroarthropathy.
Brooks AP
Diabet Med; 1986 Mar; 3(2):116-8. PubMed ID: 2951151
[No Abstract] [Full Text] [Related]
19. External fixation in the management of Charcot neuroarthropathy.
Jolly GP; Zgonis T; Polyzois V
Clin Podiatr Med Surg; 2003 Oct; 20(4):741-56. PubMed ID: 14636036
[TBL] [Abstract][Full Text] [Related]
20. Triggering mechanisms of neuroarthropathy following conservative surgery for osteomyelitis.
Aragón-Sánchez J; Lázaro-Martínez JL; Hernández-Herrero MJ
Diabet Med; 2010 Jul; 27(7):844-7. PubMed ID: 20636967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
